Nonsense suppression drug restores function in a mouse model of aniridia

Congenital aniridia is a progressive disease that is associated with improper development of eye structures as well as abnormalities in the brain and pancreas. A variety of nonsense mutations in the PAX6 gene are linked with aniridia; however, despite understanding the genetic basis of the disease, few treatment and prevention strategies are available.

In this issue of the Journal of Clinical Investigation, Cheryl Gregory-Evans and colleagues at the University of British Columbia evaluated a small molecule nonsense suppression strategy for relief of aniridia-associated defects in a mouse model of the disease. The authors developed a formulation of the nonsense suppression drug ataluren that could be given topically to postnatal aniridia mice. Administration of their ataluren-based formulation inhibited disease progression, reversed eye deformations, and restored eye function in aniridia mice.

In an accompanying commentary, José-Alain Sahel and Katia Marazova of the Institut de la Vision suggest that ataluren administration should be further explored as a therapeutic option for treatment of congenital eye defects associated with .

More information: Postnatal manipulation of Pax6 dosage reverses congenital tissue malformation defects, J Clin Invest. DOI: 10.1172/JCI70462
Toward postnatal reversal of ocular congenital malformations, J Clin Invest. 2014;124(1):81–84. DOI: 10.1172/JCI73560

add to favorites email to friend print save as pdf

Related Stories

Scientists use drug to repair rare birth defect

Dec 20, 2013

University of British Columbia and Vancouver Coastal Health scientists have developed a potential cure for a rare eye disease, showing for the first time that a drug can repair a birth defect.

Rare eye disease leaves people without an iris

Aug 02, 2013

(HealthDay)—You may never have heard of aniridia, a genetic disorder that robs people of their vision. But researchers studying the condition say it could give insight into some common health problems—from ...

New finding in rare eye disease

Jul 14, 2008

(PhysOrg.com) -- Researchers have made a finding which could pave the way for new treatments for sufferers of a rare eye disease which can lead to blindness.

Recommended for you

Study explores drug users' opinions on genetic testing

56 minutes ago

Genomic medicine is rapidly developing, bringing with its advances promises of individualized genetic information to tailor and optimize prevention and treatment interventions. Genetic tests are already guiding treatments ...

Study reveals gene expression patterns in pancreatic CTCs

Sep 22, 2014

Analysis of circulating tumor cells (CTCs) in a mouse model of pancreatic cancer identified distinct patterns of gene expression in several groups of CTCs, including significant differences from the primary tumor that may ...

User comments